Skip to Main Content

Author Details

Gerrit A Meijer
The Netherlands Cancer Institute
1992
411
74
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38088895A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics.Clin Cancer Res2024
38006283Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.Genet Med2024
38092944Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.Nat Protoc2024
36116753Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.Clin Gastroenterol Hepatol2023
38067353Identifying Genetic Mutation Status in Patients with Colorectal Cancer Liver Metastases Using Radiomics-Based Machine-Learning Models.Cancers (Basel)2023
38060377A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.Mol Oncol2023
37696619Cell-free DNA approaches for cancer early detection and interception.J Immunother Cancer2023
37921412Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case-Control Study.Cancer Res Commun2023
37321815Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial.BMJ Open2023
37463757An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.Gut2023
36402278A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.J Mol Diagn2023
36534496Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells.Clin Cancer Res2023
35053600Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.Cancers (Basel)2022
35412430Evaluation of methylated DCR1 as a biomarker for response to adjuvant irinotecan-based therapy in stage III colon cancer: cancer and leukaemia Group B 89803 (Alliance).Epigenetics2022
35842496High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.Sci Rep2022
35584320Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?Clin Transl Gastroenterol2022
35344447Reply to R. Pham et al.JCO Precis Oncol2022
35792649Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice.J Pathol2022
35395779KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer.BMC Cancer2022
35852792PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.Clin Cancer Res2022
35554535Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.Inflamm Bowel Dis2022
36463731Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.ESMO Open2022
36503495The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.BMC Cancer2022
35872559Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature.Neoplasia2022
36334560Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer.Eur J Cancer2022
36166472Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.Cancer Epidemiol Biomarkers Prev2022
36162114Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.Ann Intern Med2022
36088508Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors.Br J Cancer2022
35877698Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.PLoS One2022
33928678Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.Dig Endosc2022
34912077Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case-control study.Br J Cancer2022
35148171Genome Nexus: A Comprehensive Resource for the Annotation and Interpretation of Genomic Variants in Cancer.JCO Clin Cancer Inform2022
35143042The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.J Pathol2022
32931025Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.Histopathology2021
33842952An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.Clin Chem2021
33811727A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.Clin Transl Sci2021
33635598Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid.J Pathol Clin Res2021
33858496Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.Clin Epigenetics2021
33660299High CD8<sup>+</sup> tumour-infiltrating lymphocyte density associates with unfavourable prognosis in oesophageal adenocarcinoma following poor response to neoadjuvant chemoradiotherapy.Histopathology2021
33579196Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.BMC Gastroenterol2021
34891161Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.Gigascience2021
34820593<i>KRAS</i> A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases.JCO Precis Oncol2021
34417454Detection and characterization of lung cancer using cell-free DNA fragmentomes.Nat Commun2021
34333237Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases.EBioMedicine2021
34280333Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.Ann Intern Med2021
33341450Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.Eur J Cancer2021
33098683RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.Histopathology2021
31372648IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.Inflamm Bowel Dis2020
31936745Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors.J Clin Med2020
31784980Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.J Pathol2020
  • 1 - 50 of 411

Recommended Authors

Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year 2012
Number of shared co-authors 3
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Teodora Goranova
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2009
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 2
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 6
Darawalee Wangsa
Center for Cancer Research, National Cancer Institute
Career Start Year 2005
Number of shared co-authors 4
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 2
Alex Boussioutas
Royal Melbourne Hospital, University of Melbourne
Career Start Year 2001
Number of shared co-authors 3
Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 3
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 8
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 3
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Career Start Year 1996
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
David G Huntsman
University of British Columbia
Career Start Year 1994
Number of shared co-authors 8
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 9
Nicholas J Hawkins
School of Public Health, Imperial College London
Career Start Year 1990
Number of shared co-authors 0
Aaron Pollett
Mount Sinai Hospital
Career Start Year 1990
Number of shared co-authors 0
Robyn L Ward
University of Sydney
Career Start Year 1989
Number of shared co-authors 6
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 3
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 4
Sylviane Olschwang
Aix Marseille Universite, INSERM GMGF UMR 1
Career Start Year 1987
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 9
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 3
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 8

Collaborators

Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 79
Remond J A Fijneman
The Netherlands Cancer Institute
Co-authored papers 78
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Co-authored papers 43
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 31
Manon van Engeland
Maastricht University Medical Center
Co-authored papers 31
Meike de Wit
The Netherlands Cancer Institute
Co-authored papers 27
Eric J T Belt
Albert Schweitzer Hospital
Co-authored papers 17
Connie R Jimenez
Co-authored papers 17
Oscar Krijgsman
The Netherlands Cancer Institute
Co-authored papers 13
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 12
Jeroen A C M Goos
Karolinska Institutet
Co-authored papers 11
Kim M Smits
Maastricht University Medical Center+
Co-authored papers 10
Veerle Melotte
Maastricht University Medical Center.
Co-authored papers 10
Wim Van Criekinge
Ghent University
Co-authored papers 9
Victor E Velculescu
Co-authored papers 8
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 7
Malgorzata A Komor
Netherlands Cancer Institute
Co-authored papers 7
Emile E Voest
The Netherlands Cancer Institute
Co-authored papers 7
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 6
Fredrik Pont??n
Uppsala University
Co-authored papers 6
Jaap Heringa
VU University Amsterdam
Co-authored papers 5
Louis Vermeulen
Oncode Institute
Co-authored papers 5
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers 5
Jose Antonio Rodriguez
University of the Basque Country (UPV/EHU)
Co-authored papers 5
Youri Hoogstrate
Erasmus MC Cancer Institute
Co-authored papers 5
Jan Paul Medema
Oncode Institute
Co-authored papers 4
Edwin Cuppen
Hartwig Medical Foundation
Co-authored papers 4
Guido Jenster
Erasmus University Medical Center
Co-authored papers 4
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Co-authored papers 3
Release 1.2